Skip to main content
Rituximab‐induced acute lympholysis and pancytopenia after COVID‐19 vaccination
Published Web Location
https://onlinelibrary.wiley.com/doi/10.1002/ccr3.4517No data is associated with this publication.
Abstract
Rituximab and COVID-19 vaccine can cause massive hyperacute depletion of B cells and plasma cells, as well as subsequent cytokine release syndrome, coagulopathy, and pancytopenia. These effects differ from the adverse effects that have been reported for rituximab, and new guidelines regarding the timing of rituximab infusion and vaccination are urgently needed.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.